115 related articles for article (PubMed ID: 2453673)
1. Molecular basis for bleomycin amplification: conformational and stereoelectronic effects in unfused amplifiers.
Strekowski L; Mokrosz JL; Tanious FA; Watson RA; Harden D; Mokrosz M; Edwards WD; Wilson WD
J Med Chem; 1988 Jun; 31(6):1231-40. PubMed ID: 2453673
[TBL] [Abstract][Full Text] [Related]
2. Amplification of bleomycin-mediated degradation of DNA by polyamines.
Strekowski L; Mokrosz M; Mokrosz JL; Strekowska A; Allison SA; Wilson WD
Anticancer Drug Des; 1988 Aug; 3(2):79-89. PubMed ID: 2457380
[TBL] [Abstract][Full Text] [Related]
3. The interaction of unfused polyaromatic heterocycles with DNA: intercalation, groove-binding and bleomycin amplification.
Wilson WD; Tanious FA; Barton HJ; Wydra RL; Jones RL; Boykin DW; Strekowski L
Anticancer Drug Des; 1990 Feb; 5(1):31-42. PubMed ID: 1690546
[TBL] [Abstract][Full Text] [Related]
4. A non-classical intercalation model for a bleomycin amplifier.
Strekowski L; Wilson WD; Mokrosz JL; Strekowska A; Koziol AE; Palenik GJ
Anticancer Drug Des; 1988 Mar; 2(4):387-98. PubMed ID: 2452646
[TBL] [Abstract][Full Text] [Related]
5. Stereoelectronic factors in the interaction with DNA of small aromatic molecules substituted with a short cationic chain: importance of the polarity of the aromatic system of the molecule.
Strekowski L; Mokrosz JL; Wilson WD; Mokrosz MJ; Strekowski A
Biochemistry; 1992 Nov; 31(44):10802-8. PubMed ID: 1384699
[TBL] [Abstract][Full Text] [Related]
6. Amplification of bleomycin-mediated degradation of DNA.
Strekowski L; Strekowska A; Watson RA; Tanious FA; Nguyen LT; Wilson WD
J Med Chem; 1987 Aug; 30(8):1415-20. PubMed ID: 2441055
[TBL] [Abstract][Full Text] [Related]
7. The bleomycin amplification assay in V79 cells predicts frameshift mutagenicity of intercalative agents.
Snyder RD; Diehl MS
Mutagenesis; 2000 May; 15(3):203-5. PubMed ID: 10792011
[TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-activity relationship analysis of cation-substituted polyaromatic compounds as potentiators (amplifiers) of bleomycin-mediated degradation of DNA.
Strekowski L; Wilson WD; Mokrosz JL; Mokrosz MJ; Harden DB; Tanious FA; Wydra RL; Crow SA
J Med Chem; 1991 Feb; 34(2):580-8. PubMed ID: 1704921
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for anticancer drug amplification: interaction of phleomycin amplifiers with DNA.
Strekowski L; Chandrasekaran S; Wang YH; Edwards WD; Wilson WD
J Med Chem; 1986 Jul; 29(7):1311-5. PubMed ID: 2433446
[TBL] [Abstract][Full Text] [Related]
10. Amplification of anticancer drug-induced DNA damage and apoptosis by DNA-binding compounds.
Kawanishi S; Hiraku Y
Curr Med Chem Anticancer Agents; 2004 Sep; 4(5):415-9. PubMed ID: 15379695
[TBL] [Abstract][Full Text] [Related]
11. Amplification of pepleomycin-mediated DNA cleavage and apoptosis by unfused aromatic cations.
Kawanishi S; Oikawa S; Kawanishi M; Sugiyama H; Saito I; Strekowski L; Wilson WD
Biochemistry; 2000 Oct; 39(43):13210-5. PubMed ID: 11052673
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of the mutagenicity and recombinagenicity of bleomycin in yeast by unconventional intercalating agents.
Hoffmann GR; Laterza AM; Sylvia KE; Tartaglione JP
Environ Mol Mutagen; 2011 Mar; 52(2):130-44. PubMed ID: 20839230
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of bleomycin-induced micronucleus formation in V79 cells as a rapid and sensitive screen for non-covalent DNA-binding compounds.
Snyder RD; Strekowski L
Mutat Res; 1999 Jul; 444(1):181-92. PubMed ID: 10477353
[TBL] [Abstract][Full Text] [Related]
14. Is the bithiazole moiety of bleomycin a classical intercalator?
Hénichart JP; Bernier JL; Helbecque N; Houssin R
Nucleic Acids Res; 1985 Sep; 13(18):6703-17. PubMed ID: 2414728
[TBL] [Abstract][Full Text] [Related]
15. Potential antitumor agents. 53. Synthesis, DNA binding properties, and biological activity of perimidines designed as "minimal" DNA-intercalating agents.
Herbert JM; Woodgate PD; Denny WA
J Med Chem; 1987 Nov; 30(11):2081-6. PubMed ID: 3669016
[TBL] [Abstract][Full Text] [Related]
16. Interaction of unfused tricyclic aromatic cations with DNA: a new class of intercalators.
Wilson WD; Tanious FA; Watson RA; Barton HJ; Strekowska A; Harden DB; Strekowski L
Biochemistry; 1989 Mar; 28(5):1984-92. PubMed ID: 2719941
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of DNA intercalation potential of pharmaceuticals and other chemicals by cell-based and three-dimensional computational approaches.
Snyder RD; Ewing DE; Hendry LB
Environ Mol Mutagen; 2004; 44(2):163-73. PubMed ID: 15278920
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for potentiation of bleomycin-mediated degradation of DNA by polyamines. Experimental and molecular mechanical studies.
Strekowski L; Harden DB; Wydra RL; Stewart KD; Wilson WD
J Mol Recognit; 1989 Dec; 2(4):158-66. PubMed ID: 2484026
[TBL] [Abstract][Full Text] [Related]
19. A biphasic nature of the bleomycin-mediated degradation of DNA.
Strekowski L; Mokrosz JL; Wilson WD
FEBS Lett; 1988 Dec; 241(1-2):24-8. PubMed ID: 2461879
[TBL] [Abstract][Full Text] [Related]
20. Studies on bleomycin-DNA and bleomycin-iron interactions.
Sakai TT; Riordan JM; Kumar NG; Haberle FJ; Elgavish GA; Glickson JD; Levy A
J Biomol Struct Dyn; 1983 Dec; 1(3):809-27. PubMed ID: 6086062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
